Grytdal Scott P, DeBess Emilio, Lee Lore E, Blythe David, Ryan Patricia, Biggs Christianne, Cameron Miriam, Schmidt Mark, Parashar Umesh D, Hall Aron J
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
Public Health Division, Department of Human Services, Oregon Health Authority, Portland, OR, United States of America.
PLoS One. 2016 Apr 26;11(4):e0148395. doi: 10.1371/journal.pone.0148395. eCollection 2016.
Noroviruses and other viral pathogens are increasingly recognized as frequent causes of acute gastroenteritis (AGE). However, few laboratory-based data are available on the incidence of AGE caused by viral pathogens in the U.S. This study examined stool specimens submitted for routine clinical diagnostics from patients enrolled in Kaiser Permanente (KP) health plans in metro Portland, OR, and the Maryland, District of Columbia, and northern Virginia geographic areas to estimate the incidence of viral enteropathogens in these populations. Over a one-year study period, participating laboratories randomly selected stools submitted for routine clinical diagnostics for inclusion in the study along with accompanying demographic and clinical data. Selected stools were tested for norovirus, rotavirus, sapovirus, and astrovirus using standardized real-time RT-PCR protocols. Each KP site provided administrative data which were used in conjunction with previously published data on healthcare utilization to extrapolate pathogen detection rates into population-based incidence rates. A total of 1,099 specimens collected during August 2012 to September 2013 were included. Mean age of patients providing stool specimens was 46 years (range: 0-98 years). Noroviruses were the most common viral pathogen identified among patients with AGE (n = 63 specimens, 6% of specimens tested). In addition, 22 (2%) of specimens were positive for rotavirus; 19 (2%) were positive for sapovirus; and 7 (1%) were positive for astrovirus. Incidence of norovirus-associated outpatient visits was 5.6 per 1,000 person-years; incidence of norovirus disease in the community was estimated to be 69.5 per 1,000 person-years. Norovirus incidence was highest among children <5 years of age (outpatient incidence = 25.6 per 1,000 person-years; community incidence = 152.2 per 1,000 person-years), followed by older adults aged >65 years (outpatient incidence = 7.8 per 1,000 person-years; community incidence = 75.8 per 1,000 person-years). Outpatient incidence rates of rotavirus, sapovirus, and astrovirus were 2.0, 1.6, 0.6 per 1,000 person-years, respectively; community incidence rates for these viruses were 23.4, 22.5, and 8.5 per 1,000 person-years, respectively. This study provides the first age-group specific laboratory-based community and outpatient incidence rates for norovirus AGE in the U.S. Norovirus was the most frequently detected viral enteropathogen across the age spectrum with the highest rates of norovirus disease observed among young children and, to a lesser extent, the elderly. These data provide a better understanding of the norovirus disease burden in the United States, including variations within different age groups, which can help inform the development, targeting, and future impacts of interventions, including vaccines.
诺如病毒和其他病毒病原体日益被认为是急性胃肠炎(AGE)的常见病因。然而,关于美国病毒病原体所致AGE发病率的基于实验室的数据很少。本研究检查了俄勒冈州波特兰市、马里兰州、哥伦比亚特区以及弗吉尼亚州北部地理区域内参加凯撒医疗集团(KP)健康计划的患者提交的用于常规临床诊断的粪便标本,以估计这些人群中病毒性肠道病原体的发病率。在为期一年的研究期间,参与研究的实验室随机选择提交用于常规临床诊断的粪便,连同相关的人口统计学和临床数据纳入研究。使用标准化的实时逆转录聚合酶链反应(RT-PCR)方案对选定的粪便进行诺如病毒、轮状病毒、札如病毒和星状病毒检测。每个KP地点提供管理数据,这些数据与先前发表的医疗保健利用数据一起用于将病原体检测率外推为基于人群的发病率。共纳入了2012年8月至2013年9月期间收集的1099份标本。提供粪便标本的患者平均年龄为46岁(范围:0 - 98岁)。诺如病毒是在AGE患者中鉴定出的最常见病毒病原体(n = 63份标本,占检测标本的6%)。此外,22份(2%)标本轮状病毒呈阳性;19份(2%)札如病毒呈阳性;7份(1%)星状病毒呈阳性。诺如病毒相关门诊就诊发病率为每1000人年5.6例;社区中诺如病毒病发病率估计为每1000人年69.5例。诺如病毒发病率在5岁以下儿童中最高(门诊发病率 = 每1000人年25.6例;社区发病率 = 每1000人年152.2例),其次是65岁以上老年人(门诊发病率 = 每1000人年7.8例;社区发病率 = 每1000人年75.8例)。轮状病毒、札如病毒和星状病毒的门诊发病率分别为每1000人年2.0例、1.6例、0.6例;这些病毒的社区发病率分别为每1000人年23.4例、22.5例和8.5例。本研究提供了美国首个基于实验室的诺如病毒AGE按年龄组划分的社区和门诊发病率。诺如病毒是在各个年龄段中最常检测到的病毒性肠道病原体,幼儿中诺如病毒病发病率最高,老年人中发病率相对较低。这些数据有助于更好地了解美国诺如病毒疾病负担,包括不同年龄组之间的差异,这可为干预措施(包括疫苗)的制定、目标设定及其未来影响提供参考。